(1)
Shanehsaz, S. M.; Ishkhanian, S. Therapeutic and Adverse Effects of Standard-Dose and Low-Dose Meglumine Antimoniate During Systemic Treatment of Syrian Cutaneous Leishmaniasis Patients. J Pak Assoc Dermatol 2016, 24, 115-121.